RankingsPricing
  1. US-listed companies
  2. Teladoc Health, Inc.
  3. Raw

Teladoc Health, Inc.TDOC

Market cap
$1.2B
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
Net loss-58-74-107-97-99-485-429-13,660-220-1,001
Goodwill impairment-------13,403-790
Amortization of intangible assets----3665195245326363
Depreciation, Nonproduction--------1110
Amortization of right-of-use assets-----7--129
Provision for allowances for doubtful accounts222235171554
Stock-based compensation38314467476303218202146
Deferred income taxes---------2-1
Other, net------4-80-10
Accounts receivable7341116211862100
Prepaid expenses and other current assets11233133141-12-5
Inventory-----2519-15-2410
Other assets-00-0008428231
Accounts payable-1-12-01-8812-4-10
Accrued expenses and other current liabilities3-24415201861930
Accrued compensation3248535-5-1219-20
Deferred revenue---------5-18
Operating lease liabilities---------10-11
Other liabilities21-311-230-1-0
Net cash provided by operating activities---34-530-54194189350294
Capital expenditures6234449161111
Capitalized software development costs-------156145113
Proceeds from marketable securities----522503--
Other, net-------9-3-0-
Net cash used in investing activities---448-25725-591-73-168-156-124
Proceeds from Stock Options Exercised-31131335426614
Proceeds from employee stock purchase plan--2335177105
Other, net-------4-3--0
Net cash provided by financing activities--47564635859416118
Net increase in cash and cash equivalents----9021516228205178
Effect of foreign currency exchange rate changes----04-2-31-3
Income Taxes Paid, Net--00114379
Interest paid22910121516171717
Accruals related to Property and equipment, net and Intangible assets, net--------114